by Kamile Gruduls | Jul 2, 2021 | Pharmacovigilance
During the last years, there has been a skyrocketing demand for pharmacovigilance as medicinal products consumption is growing and disorders and diseases are becoming more prevalent. To top this, an increasing number of adverse drug reactions (ADRs) is becoming a...
by Nick | Jul 1, 2021 | Pharmacovigilance
Setting Up a Pharmacovigilance System from Scratch In the EU/EEA, US, and other major pharmaceutical markets, you need a sound plan for post-market surveillance for your medicinal product’s Market Authorization Application (MAA). A robust pharmacovigilance (PV)...
by Kamile Gruduls | Jun 9, 2021 | Pharmacovigilance, Webinar
Webinar: Strategic Pharmacovigilance Activities. Scalable and Tailor-made Outsourcing Models Larger companies often limit their strategic pharmacovigilance activities outsourcing only to highly manual and repetitive tasks, while the smaller ones may want to outsource...
by Nick | Jun 1, 2021 | Pharmacovigilance
Advantages of QPPV Outsourcing in the EU/EEA Pharmaceutical companies with a primary base outside the EU, companies without in-house PV capabilities or companies with business decisions to refocus their workload on core strategic competencies often look to externalize...
by Nick | Mar 11, 2021 | Pharmacovigilance
Health information that has been posted online by patients can efficiently supplement your post-marketing drug safety data gained from traditional sources. Data harvesting from Social Networking Sites (SNS) has a lot of potential and significant advantages when...
by Nick | Oct 21, 2020 | Pharmacovigilance, Regulatory Affairs
Scientists, doctors, and health authorities often use written communication to present their research, opinions, or guidelines to the patients. While the questions they approach may be complex, the language should not. In medical documents, misinterpreted information...
